Skip to search formSkip to main contentSkip to account menu

R 56865

Known as: R-56865, R56865 
National Institutes of Health

Related topics

Related topics

3 relations

Broader (3)

BenzothiazolesCalcium Channel BlockersPiperidines

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2008
2008
H(2)O(2)-induced left ventricular dysfunction in isolated working rat hearts is independent of calcium accumulation.
Review
1999
Review
1999
Drugs preventing Na+ and Ca2+ overload.
Cardiac intracellular Na+and Ca2+homeostasis is regulated by the concerted action of ion channels, pumps and exchangers. The Na… 
1997
1997
'Wide-spectrum Ca2+ channel antagonists': lipophilicity, inhibition, and recovery of secretion in chromaffin cells.
1995
1995
Pharmacological protection against the cytotoxicity induced by 6-hydroxydopamine and H2O2 in chromaffin cells.
1995
1995
Effects of Ca2+ channel antagonist subtypes on mitochondrial Ca2+ transport.
1994
1994
Effects of Ca2+ channel antagonists on chromaffin cell death and cytosolic Ca2+ oscillations induced by veratridine.
1993
1993
R56865 inhibits catecholamine release from bovine chromaffin cells by blocking calcium channels
1 The effects of R56865 (a new class of cardioprotective agent which prevents Na+ and Ca2+ overload in cardiac myocytes) on… 
1991
1991
Preferential block of the veratridine-induced, non-inactivating Na+ current by R56865 in single cardiac Purkinje cells.
1991
1991
Block of the transient inward current by R56865 in guinea-pig ventricular myocytes.
1990
1990
R56865, a Potent New Antiarrhythmic Agent, Effective During Ischemia and Reperfusion in the Rat Heart
The antiarrhythmic effects of R56865 were characterized both in vivo and in vitro. Four groups (n = 12 per group) of anesthetized… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)